• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
ClinicalIn two studies with 387 patients it is very uncertain whether there is a clinically important difference in the number of people with recurrent VTE between the intensive information group and the usual care group (VERY LOW QUALITY).
In two studies of 287 patients it is it is unlikely there is a clinically important difference in major bleeding between the group receiving intensive education and the group receiving usual care (VERY LOW QUALITY).
In one study of 302 patients it is unlikely that there is any difference of clinical importance in patient knowledge in the group receiving tailored intensive education compared to the group receiving usual care (LOW QUALITY).
In one study of 85 patients it is unlikely that there is any difference of clinical importance in compliance in the group receiving intensive education compared to the group receiving usual care (LOW QUALITY).
In one study of 152 patients it is unlikely that there is any difference of clinical importance in the percentage time spent within target INR in the group receiving brochures compared to the group receiving no intervention (LOW QUALITY).
In one study of 143 patients it is unlikely that there is any difference of clinical importance in the percentage time spent within target INR in the group receiving a course (group education) compared to the group receiving no intervention (LOW QUALITY).
In one study of 141 patients it is unlikely that there is any difference of clinical importance in the percentage time spent within target INR in the group receiving a course (group education) compared to the group receiving brochures (LOW QUALITY).
In one study of 81 patients it is unlikely that there is any difference of clinical importance in the percentage time spent within target INR in the group receiving intensive individual education compared to the group receiving usual care (LOW QUALITY).
EconomicNo economic evidence was found on this question.

From: 11, Patient information

Cover of Venous Thromboembolic Diseases
Venous Thromboembolic Diseases: The Management of Venous Thromboembolic Diseases and the Role of Thrombophilia Testing [Internet].
NICE Clinical Guidelines, No. 144.
National Clinical Guideline Centre (UK).
Copyright © 2012, National Clinical Guideline Centre.

Apart from any fair dealing for the purposes of research or private study, criticism or review, as permitted under the Copyright, Designs and Patents Act, 1988, no part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.

The rights of National Clinical Guideline Centre to be identified as Author of this work have been asserted by them in accordance with the Copyright, Designs and Patents Act, 1988.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.